网络毒理学和分子对接策略用于分析双甲在高血压中的毒性和机制
Wenjie Zhang1,2, Yinming Zhang3, Jiawei Tang4
1Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, No. 5, Beixiange Road, Xicheng District, Beijing 100053, China.
Toxicology research
|July 25, 2025
概括
环境污染,比如双A (BPA),可以导致高血压. 这项研究揭示了BPA.
科学领域:
- 环境毒理学和心血管研究.
- 计算毒理学和分子生物学.
背景情况:
- 环境污染是高血压的重要危险因素.
- 双A (BPA) 是一种广泛存在的环境污染物,与健康问题有关.
研究的目的:
- 为了研究BPA的心脏毒性.
- 通过网络毒理学和分子对接,阐明BPA诱导的高血压背后的分子机制.
主要方法:
- 网络毒理方法用于识别潜在的BPA目标.
- 基因本体学 (GO) 和基因和基因组的京都百科全书 (KEGG) 路径丰富分析.
- 分子对接以确认BPA与核心目标的结合.
主要成果:
- 对BPA对高血压的影响确定了51个潜在目标和14个核心目标.
- 核心目标主要涉及雌激素和信号通路.
- 确认BPA对核心目标具有约束力,ADRB2,ESR1和MMP9被确定为关键参与者.
结论:
- 通过特定的分子通路,BPA暴露会导致高血压.
- 阐明了BPA在高血压发展中的毒性机制.
- 为管理与环境BPA暴露相关的高血压提供了基础.
更多相关视频
07:08Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
Published on: March 6, 2018
6.2K
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
14.1K
相关概念视频
Toxic Reactions: Overview
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Toxicokinetics: Overview
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
